AI Terminal
Q-Linea
Board/Management Information • Feb 16, 2023
3100_rns_2023-02-16_651f97af-ff10-4b0f-bc4f-1f6e95d37659.pdf
Board/Management Information
Open in ViewerOpens in native device viewer
Q-linea hires new CFO
Q-linea AB (publ) (OMX: QLINEA) today announces that the company has hired Christer Samuelsson as CFO and IR. Christer Samuelsson takes office on May 1, 2023 when he succeeds Anders Lundin, who has held the position since 2018. Anders Lundin will end his contract in connection with the annual general meeting in May.
Christer Samuelsson has solid experience as CFO from several industries, partly in life science, but also from fast-growing listed and unlisted companies in the renewable energy sector. In addition, Christer has many years of experience from the financial sector.
"I am very happy that Christer has chosen to accept the position as CFO and IR at Q-linea. His experience is impressive and his attitude and willingness to support the organisation to grow commercially in multiple geographies is inspiring. I am convinced that the work will continue to be delivered with the same high quality that Anders has maintained. Anders has expressed a desire to step down and to devote more time to personal interests. Anders and I have had a very good collaboration for five years and I wish Anders all the best in the future," said Jonas Jarvius, CEO of Q-linea.
For more information, please contact:
Jonas Jarvius, CEO, Q-linea AB [email protected] +46 (0) 70-323 77 60
Anders Lundin, CFO, Q-linea AB [email protected] +46 (0) 70-600 15 20
About Q-linea
Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company's lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.